EvoMG-DN · Evolutionary Medical Genomics Doctoral Network
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2026-01-01 → 2029-12-31
- Финансиране от ЕС
- 4 601 373 €
- Участници
- 22
- Схема
- HORIZON-TMA-MSCA-DN
Линиите свързват координатора с партньорите.
Накратко на български
Еволюционната медицинска геномика изследва как промените в гените влияят върху стареенето, развитието на рака и устойчивостта на бактериите към антибиотици. Това помага за подобряване на клиничните приложения, като например създаването на адаптивни терапии при ракови заболения.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
The Evolutionary Medical Genomics Doctoral Network (EvoMG-DN) pioneers an integrative approach combining Evolutionary Medicine and Medical Genomics to address critical health challenges. By combining evolutionary insights with state-of-the-art genomic tools, EvoMG-DN seeks to establish EvoMG as a structured and impactful discipline in Europe. The network aims to train the next generation of interdisciplinary researchers to unlock the full potential of evolutionary genomic approaches in healthcare.EvoMG-DN pursues three overarching objectives: (i) foster interdisciplinary synergy by uniting EvoMG researchers from diverse fields to catalyze innovation in methodologies and tools; (ii) create a cohesive training framework, equipping doctoral candidates (DCs) with expertise in EvoMG applications through structured training and collaboration; and (iii) advance evolution-informed clinical applications, such as adaptive cancer therapies.The research program is organized into three scientific work packages: WP1 explores evolutionary insights into ageing and age-related diseases; WP2 focuses on tumor evolution and acquisition of resistance in cancer therapies; and WP3 addresses pathogen evolution, antibiotic resistance and interactions with the immune system. These are underpinned by core methodological pillars, which include comparative functional genomics, genetic diversity analysis, mathematical modeling and machine learning, and the use of unconventional model organisms.Through interdisciplinary secondments, tailored mentoring, and advanced training modules, EvoMG-DN empowers DCs to bridge disciplines and develop actionable solutions to global health challenges. By formalizing EvoMG methodologies and advancing clinical applications, EvoMG-DN aims to solidify Europe’s leadership in biomedical research and deliver long-lasting societal impact.
Оригинален текст от CORDIS (на английски).
Участници
- FUNDACIO CENTRE DE REGULACIO GENOMICA · BarcelonaКоординаторИспания
- BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION · BARCELONAИспания
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS · ParisФранция
- CHALMERS TEKNISKA HOGSKOLA AB · GoteborgШвеция
- DUKE UNIVERSITY · Durham NcСъединени щати
- ECOLE NORMALE SUPERIEURE · ParisФранция
- EUROPEAN MOLECULAR BIOLOGY ORGANIZATION · GeneveШвейцария
- FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA · LisboaПортугалия
- FRIEDRICH-SCHILLER-UNIVERSITÄT JENA · JENAГермания
- FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE · LISBOAПортугалия
- FUNDACIO D'ESTUDIS I RECERCA ONCOLOGICA (FERO) · BarcelonaИспания
- INSTITUT PASTEUR · ParisФранция
- INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG · LondonОбединеното кралство
- LEIBNIZ-INSTITUT FUR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT EV (FLI) LEIBNIZ INSTITUTE ON AGING - FRITZ LIPMANN INSTITUTE EV (FLI) · JenaГермания
- Mashauri Limited · AddlestoneОбединеното кралство
- Microomics Systems S.L. · BarcelonaИспания
- Nonacus Ltd · WalsallОбединеното кралство
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE · CAMBRIDGEОбединеното кралство
- UNIVERSIDAD POMPEU FABRA · BarcelonaИспания
- UNIVERSITAT DE BARCELONA · BarcelonaИспания
- UNIVERSITE PARIS CITE · ParisФранция
- UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN · DublinИрландия
Връзки
Данни: CORDIS, © Европейски съюз